The combination of subcutaneous daratumumab with VRd was approved in July 2024 for induction and consolidation in patients ...

Recent clinical developments in the treatment of platinum-resistant ovarian cancer (PROC) have introduced several novel therapeutic classes, including selective glucocorticoid receptor antagonists, ...

From FDA actions to new standard-of-care potential, the breast cancer treatment arsenal continues to expand. This week’s news ...

About 15,000 registered nurses at several of New York City’s major hospitals walked off the job Jan 12 after contract ...

Data from the COMMIT trial demonstrated that the addition of oxaliplatin, leucovorin, 5-fluorouracil (mFOLFOX6) and ...

“Oncology nurses are unique in that we see patients for a long time. We get to know their families. We see them through graduation, through weddings, progression of disease, recurrence,” said ...

Deborah (Debi) A. Boyle MSN, RN, AOCNS, FAAN, is editor in chief of Oncology Nursing News®. She is a long tenured oncology clinical nurse specialist who has practiced in both Comprehensive Cancer ...

Age, Parental Status Factors in Fertility Decisions in Premenopausal Breast Cancer ...

Transportation is a key accessibility issue for patients with HR-positive metastatic breast cancer receiving CDK4/6 inhibitors at community clinics.

When a patient with renal cell carcinoma (RCC) progresses on or following the combination of a tyrosine kinase inhibitor (TKI) and immunotherapy, advanced practice providers (APPs) can use patient ...

Findings from a real-world, head-to-head comparison show greater colorectal cancer risk reduction and safety with the use of a GLP-1RA vs aspirin.